Sinobioway Group

Enerkem Inc. is a Canadian cleantech company based in Montreal, specializing in the production of renewable biofuels and chemicals from non-recyclable municipal solid waste. Founded in 2000, Enerkem has developed a proprietary thermochemical technology that efficiently converts waste into biofuels, primarily cellulosic ethanol, and renewable chemicals. This patented process chemically recycles the carbon in waste materials, creating a synthesis gas that is transformed into biofuels and chemicals using commercially available catalysts. With a focus on addressing the challenges of oil dependence and waste disposal, Enerkem aims to produce these renewable products at commercial scale. The company has undertaken extensive validation of its technology over a decade, utilizing solid waste from various municipalities. Enerkem employs around 170 people across Canada and the United States and has established strategic partnerships to support its mission of advancing sustainable energy solutions.

EXUMA Biotech Corp. is a clinical-stage biotechnology company focused on the discovery and development of adoptive cellular therapies for solid tumors and hematological malignancies. The company specializes in chimeric antigen receptor-T cell therapy, aiming to enhance the immune system's ability to combat various cancers, including renal cell carcinoma, soft tissue sarcoma, and gastric cancer. Founded in 2015, EXUMA Biotech is headquartered in West Palm Beach, Florida, with additional locations in San Diego, California, Grand Cayman, Cayman Islands, and Shanghai, China. The company is committed to pioneering innovative solutions in cell and gene therapy, leveraging its logic-gated CAR-T platform to improve patient access to these advanced treatment options.